iShares US Healthcare ETF

IYH

Market cap $3.55B

iShares U.S. Healthcare ETF receives a hold rating due to concerning signals from its top holdings and elevated valuations. IYH's heavy concentration in LLY, JNJ, and ABBV exposes the fund to slowing growth, regulatory pressures, and high forward P/E ratios. GLP-1 market risks, muted growth at JNJ, and ABBV's patent expirations threaten IYH's forward performance and capital appreciation.

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund launched on June 12, 2000.

IYH hits a 52-week high as healthcare gains momentum, lifted by sector strength and rising investor interest in safety and AI-driven tailwinds.

The Investment Committee give you their top stocks to watch for the second half.

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs.

The iShares U.S. Healthcare ETF (IYH) was launched on June 12, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.

This article provides a top-down view of the healthcare sector based on fundamental metrics. Healthcare providers and pharmaceutical/biotechnology subsectors are undervalued versus 11-year averages. Fast facts on iShares U.S. Healthcare ETF, an alternative to XLV.

Over the past month, the market has undergone a rotation that's seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market's footing.

The iShares U.S. Healthcare ETF (IYH) was launched on June 12, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.